204 related articles for article (PubMed ID: 32833021)
21. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
22. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.
Kim YT; Serrano B; Lee JK; Lee H; Lee SW; Freeman C; Oh JK; Alemany L; Bosch FX; Bruni L
Papillomavirus Res; 2019 Jun; 7():26-42. PubMed ID: 30599280
[TBL] [Abstract][Full Text] [Related]
23. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
24. Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
Wu J; Xiao F; Zheng Y; Lin Y; Wang HL
Cancer; 2021 Sep; 127(17):3172-3182. PubMed ID: 33974715
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
26. Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.
Aninye IO; Berry-Lawhorn JM; Blumenthal P; Felder T; Jay N; Merrill J; Messman JB; Nielsen S; Perkins R; Rowen T; Saslow D; Trimble CL; Smith-McCune K
J Womens Health (Larchmt); 2021 Dec; 30(12):1667-1672. PubMed ID: 34871035
[TBL] [Abstract][Full Text] [Related]
27. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
28. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
29. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
Cody P; Tobe K; Abe M; Elbasha EH
BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
[TBL] [Abstract][Full Text] [Related]
30. High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine Introduction.
Mix JM; Saraiya M; Senkomago V; Unger ER
Am J Prev Med; 2022 Jan; 62(1):95-99. PubMed ID: 34922655
[TBL] [Abstract][Full Text] [Related]
31. Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
Ryser MD; Rositch A; Gravitt PE
J Infect Dis; 2017 Sep; 216(5):604-611. PubMed ID: 28931221
[TBL] [Abstract][Full Text] [Related]
32. Risk of Anal Cancer in Women With a Human Papillomavirus-Related Gynecological Neoplasm: Puerto Rico 1987-2013.
Acevedo-Fontánez AI; Suárez E; Torres Cintrón CR; Ortiz AP
J Low Genit Tract Dis; 2018 Jul; 22(3):225-230. PubMed ID: 29649025
[TBL] [Abstract][Full Text] [Related]
33. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.
Clark E; Chen L; Dong Y; Raychaudhury S; White D; Kramer JR; Chiao E
Clin Infect Dis; 2021 May; 72(9):e359-e366. PubMed ID: 32785700
[TBL] [Abstract][Full Text] [Related]
34. Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer.
Cook EE; Gershman ST; Kim JJ; Tamimi RM; Klevens RM; Holmes MD
Cancer Causes Control; 2018 May; 29(4-5):435-443. PubMed ID: 29497883
[TBL] [Abstract][Full Text] [Related]
35. Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review.
Sethi S; Poirier B; Canfell K; Smith M; Garvey G; Hedges J; Ju X; Jamieson LM
BMJ Open; 2021 Jun; 11(6):e050113. PubMed ID: 34193502
[TBL] [Abstract][Full Text] [Related]
36. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
37. Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.
Priyadarshini M; Prabhu VS; Snedecor SJ; Corman S; Kuter BJ; Nwankwo C; Chirovsky D; Myers E
Front Public Health; 2020; 8():624092. PubMed ID: 33665180
[No Abstract] [Full Text] [Related]
38. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
39. Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study.
Schulte-Frohlinde R; Georges D; Clifford GM; Baussano I
Am J Epidemiol; 2022 Feb; 191(3):402-412. PubMed ID: 34652438
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus-Associated Cancers.
Alhamlan FS; Alfageeh MB; Al Mushait MA; Al-Badawi IA; Al-Ahdal MN
Adv Exp Med Biol; 2021; 1313():1-14. PubMed ID: 34661888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
